Business Wire

FPT-SOFTWARE

5.9.2022 17:47:27 CEST | Business Wire | Press release

Share
FPT Software Opens New Office in Denmark, Targeting Nordic Region

FPT Software, Vietnam’s leading IT solutions provider, recently announced the opening of its first office in the Scandinavian region and the 59th office internationally.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220905005353/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

From left to right, FPT Software Europe CEO, Mr. Le Hai; FPT Corporation Chairman, Dr. Truong Gia Binh; Denmark’s State Secretary for Trade and Global Sustainability, H.E. Ms. Lina Gandløse Hansen; Vietnamese Ambassador to Denmark, H.E. Mr. Luong Thanh Nghi; Vido Group Founder, Ms. Nguyen Tuyet Mai; Vido Group Denmark CEO, Mr. Jesper G. Jensen. (Photo by Vietnam News Agency)

Within the framework of the Vietnam - Denmark Business Forum, FPT Software and Vido Group, Vietnam’s leading travel services provider, had a joint ribbon-cutting ceremony, marking both companies’ first footprint in Denmark. The event was hosted by the Embassy of Vietnam in Denmark, FPT Software and Vido Group, and was attended by Denmark’s State Secretary for Trade and Global Sustainability, H.E. Ms. Lina Gandløse Hansen, Vietnamese Ambassador to Denmark, H.E. Mr. Luong Thanh Nghi, and executives from Vietnam and Denmark’s companies.

The new office extends FPT Software’s presence in Europe to seven countries and aims at exploring opportunities for sustainable and innovative business growth. It is located in Kongens Lyngby, a commercial area and home to major companies, including Microsoft, COWI A/S, Bang & Olufsen, among others.

“Denmark is one of Vietnam’s largest foreign investors. As Vietnam’s leading corporation, FPT believes that with this newly opened office, we could contribute to strengthening the relationship between the two countries and act as a bridge between both sides’ businesses," FPT Chairman, Dr. Truong Gia Binh said. “We are committed to accompanying Danish and other Nordic customers with our investments, digital technologies, and talents,” he pledged.

“I am very pleased to see FPT Software, a Vietnamese pioneering company in IT services, open its representative office in Denmark. This is the first time a big Vietnamese enterprise has set foot in the Danish market, one with very high standards. FPT Software's presence in Denmark, one of the world's leading countries in technology and digital transformation, has shown that Vietnamese businesses can fully reach out to the world,” Vietnamese Ambassador to Denmark Luong Thanh Nghi said.

“I believe that the presence of enterprises like FPT in Denmark or Carlsberg and LEGO in Vietnam will contribute to promoting, strengthening, and deepening the comprehensive partnership between Vietnam and Denmark. The Embassy of Vietnam in Denmark is committed to supporting and serving the interests of the people and businesses of the two countries,” Vietnamese Ambassador to Denmark Luong Thanh Nghi added.

The ceremony was followed by two panel discussions on how businesses and governments of Vietnam and Denmark can cooperate to promote digital transformation and green transition, as demonstrated by successful cases and experiences from top enterprises like LEGO, Covestro, and Schaeffler. As the Head of the Private Economic Development Research Board under the Government's Advisory Council on Administrative Procedure Reform, Dr. Truong Gia Binh also shared his insights on these matters.

Scandinavia has been at the forefront of digital transformation. Being the region’s success story, the Danish Government recently launched a new digitalization strategy in May 2022 with the vision to accelerate green transition, increase growth, talents, and exports with digital innovations. This provides foreign investors in such fields as AI, Fintech, Robotics, among others, with opportunities to expand in Scandinavia. With the new office in Denmark, FPT Software can extend its support to organizations in the region to address their demands on digital talent and emerging technologies.

The newly inaugurated office asserts FPT Software’s rapid growth and a strong commitment to expanding its European team. 2022 marks FPT Software’s 10th year of operation in Europe. After a decade, FPT Software Europe currently has 500 employees working across seven countries in the region and serves a clientele of nearly 100 organizations, including RWE, Schaeffler, Airbus, E.ON, and more. The company sets sights on becoming one of the Top 10 Digital Transformation services providers in Europe by 2025.

About FPT Software

FPT Software is a global technology and IT services provider headquartered in Vietnam, with more than USD 632.5 million in revenue and 25,500 employees in 28 countries. As a pioneer in digital transformation, the company delivers world-class services in Smart factory, Digital platforms, RPA, AI, IoT, Cloud, AR/VR, BPO, and more. It has served 1,000+ customers worldwide, a hundred of which are Fortune Global 500 companies in the industries of Automotive, Banking and Finance, Logistics & Transportation, Utilities, and more. For further information, please visit http://www.fpt-software.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220905005353/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release

- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release

Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release

Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye